Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Radioiodinated metaiodobenzylguanidine (MIBG) imaging has been used to evaluate adrenergic nerve activity in different organs Cardiac and pulmonary MIBG uptake is important in predicting the prognosis of certain cardiopulmonary diseases. It has been reported that cardiac MIBG uptake decreases with age and is significantly lower in the elderly. However, there has been no systemic study on age-related changes in cardiac and pulmonary MIBG uptake in children. This study was undertaken to determine the changes in MIBG uptake in the developing heart and lung in children and adolescents.
Methods and Results
MIBG scans of 44 children (16 female and 28 male; age range, 2 months to 19 years) without abnormal uptake were selected from a large pool of patients with whole-body MIBG imaging performed for evaluation of neuroblastoma. All of the selected subjects had a normal physiologic distribution of MIBG and no history of heart or lung diseases. The patients were divided into 4 groups by age: group 1, 0 to 24 months; group 2, 25 to 48 months; group 3, 49 to 72 months; and group 4, 73 months or greater. Cardiac and pulmonary MIBG uptake values (expressed as heart-to-mediastinum [H/M] ratio and lung-to-mediastinum [L/M] ratio, respectively) were determined and compared among the 4 groups. H/M and L/M ratios were noted to decrease with age. The mean H/M and L/M ratios were in group 1, 4.13±0.66 and 1.53±0.18, respectively; in group 2, 3.46±0.71 and 1.26±0.18, respectively; in group 3, 3.19±0.94 and 1.13±0.17, respectively; and in group 4, 2.84±0.48 and 1.14±0.14, respectively. There was a significant inverse correlation between H/M ratio and age (r=0.711, P<.001) as well as between L/M ratio and age (r=0.718, P<.001).
Cardiac and pulmonary MIBG uptake is inversely related to age in children.
- Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med 1981;22:129–32.
- Tobes MC, Jaques S Jr, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985;26:897–907.
- Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22–31.
- Mangner TJ, Tobes MC, Wieland DW, Sisson JC, Shapiro B. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 1986;27:37–44.
- Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981;305:12–7.
- Lynn MD, Shapiro B, Sisson JC, Swanson DP, Mangner TJ, Wieland DM, et al. Portrayal of pheochromocytoma and normal human adrenal medulla by m-iodobenzylguanidine: concise communication. J Nucl Med 1984;25:436–40.
- Kimmig B, Brandeis WE, Eisenhut M, Bubeck B, Hermann HJ, zum Winkel K. Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine. J Nucl Med 1984;25:773–5.
- Hickeson MP, Charron M, Maris JM, Brophy P, Kang TI, Zhuang H, et al. Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma. Pediatr Blood Cancer 2004;42:268–74. CrossRef
- Dae MW, O'Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79:634–44.
- Fagret D, Wolf JE, Vanzetto G, Borrel E. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med 1993;34:57–60.
- Sisson JC, Shapiro B, Meyers L, Mallette S, Manger TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625–36.
- Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 1980; 21:349–53.
- Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Castaigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med 1999;40:224–31.
- Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252–8. CrossRef
- Gill JS, Hunter GJ, Gane J, Ward DE, Camm AJ. Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a “clinically normal” heart. Br Heart J 1993;69:6–13. CrossRef
- Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999; 33:759–66. CrossRef
- Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917–23.
- Iwasa K, Nakajima K, Yoshikawa H, Tada A, Taki J, Takamon M. Decreased myocardial 123I-MIBG uptake in Parkinson’s disease. Acta Neurol Scand 1998;97:303–6. CrossRef
- Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 2006;13:34–42. CrossRef
- Cowen T, Haven AJ, Wen-Qin C, Gallen DD, Franc F, Burnstock G. Development and ageing of perivascular adrenergic nerves in the rabbit. A quantitative fluorescence histochemical study using image analysis. J Auton Nerv Syst 1982;5:317–36. CrossRef
- Bruzzone P, Cavallotti C, Mancone M. Tranquilli Leali FM Age-related changes in catecholaminergic nerve fibers of rat heart and coronary vessels. Gerontology 2003;49:80–5. CrossRef
- Kiyono Y, Kanegawa N, Kawashima H, Lida Y, Kinoshita T, Tamaki N, et al. Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging. Nucl Med Biol 2002;29:679–84. CrossRef
- Somsen GA, Born JJ, Dubois EA, Schook MB, Van Der Wall EE, Van Royen EA. Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies. Nucl Med Commun 1996;17:872–6. CrossRef
- Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol 1995;2:126–32.
- Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995;36:969–74.
- Sakata K, Shirotani M, Yoshida H, Kurata C. Physiological fluctuation of the human left ventricle sympathetic nervous system assessed by iodine-123-MIBG. J Nucl Med 1998;39:1667–71.
- Slosman DO, Davidson D, Brill AB, Alderson PO. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function. Eur J Nucl Med 1988;13:543–7. CrossRef
- Slosman DO, Donath A, Alderson PO. 131I-metaiodobenzylguanidine and 125I-iodoamphetamine. Parameters of lung endothelial cell function and pulmonary vascular area. Eur J Nucl Med 1989;15:207–10. CrossRef
- Slosman DO, Morel DR, Mo Costabella PM, Donath A. Lung uptake of 131I-metaiodobenzylguanidine in sheep. An in vivo measurement of pulmonary metabolic function. Eur J Nucl Med 1988;14:65–70.
- Arao T, Takabatake N, Sata M, Abe S, Shibara Y, Honma T, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med 2003;44:1747–54.
- Takabatake N, Arao T, Sata M, Abe S, Inoue S, Shibata Y, et al. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy. Eur J Nucl Med Mol Imaging 2005; 32:221–8. CrossRef
- Koizumi T, Kubo K, Hanaoka M, Yamamoto H, Yamaguchi S, Fujii T, et al. Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high-altitude pulmonary edema. Chest 1999;116:1129–31. CrossRef
- Suga K, Kume N, Shimizu K, Nishigauchi K, Hara A, Motoyama K, et al. Potential of iodine-123 metaiodobenzylguanidine single-photon emission tomography to detect abnormal functional status of the pulmonary neuroadrenergic system in irradiated lung. Eur J Nucl Med 1999;26:647–54. CrossRef
- Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, et al. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992; 19:10–6. CrossRef
- Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–7.
- Dae MW, Botvinick EH. Imaging of the heart using metaiodobenzylguanidine. J Thorac Imaging 1990;5:31–6. CrossRef
- Goldber PB, Kreider MS, McLean MR, Roberts J. Effects of aging at the adrenergic cardiac neuroeffector junction. Fed Proc 1986;45:45–7.
- White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994;90:1225–38.
- Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000;259:353–82. CrossRef
- Scholz DG, Kitzman DW, Hagen PT, Hstrup DM, Edwards WD. Age-related changes in normal human hearts during the first 10 decades of life Part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old [published erratum appears in Mayo Clin Proc 1988;63:637]. Mayo Clin Proc 1988;63:126–36.
- Iversen LL. Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 1971;41:571–91.
- Lightman SL, Iversen LL. The role of uptake 2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol 1969;37:638–49.
- Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350–4. CrossRef
- Glowniak JV. Cardiac uptake of MIBG in patients with aortic stenosis. J Nucl Med 1993;34:1392–5.
- Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620–4.
- Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, et al. Todine-131 metaiodobenzylguanidine intra- and extravesicular accumlation in the rat heart. J Nucl Med 1986;27:84–9.
- Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Todine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182–91.
- Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts—implications for clinical studies. J Nucl Med 1992;33:1444–50.
- Gasnier B, Roisin MP, Scherman D, Coornaert S, Desplanches G, Henry JP. Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol 1986;29:275–80.
- Mandela P, Ordway GA. The aorepinephrine transporter and its regulation. J Neurochem 2006;97:310–33. CrossRef
- Nakajo M, Shapiro B, Glowniak J, Sisson JC Beierwaltes WH. Inverse relationship between cardiac accumulation of meta-[131I] iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 1983; 24:1127–34.
- Mardon K, Montagne O, Elbaz N, Malek Z, Syrota A, Dubois-Rande JL, et al. Uptake-I carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J Nucl Med 2003;44:1459–66.
- Vigas M, Celko J, Jurankova E, Jezova D, Kvetnansky R. Plasma catecholamines and renin activity in wrestlers following vigorous swimming. Physiol Res 1998;47:191–5.
- Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192–9.
- Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 1982;44:269–81. CrossRef
- Sole MJ, Drobac M, Schwartz L, Hussain MN, Vaughan-Neil EF. The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 1979;60:160–3.
- Glowniak JV, Wilson RA, Joyce ME, Turner EF. Evaluation of metaiodobenzylguanidine heart and lung extraction fraction by first-pass analysis in pigs. J Nucl Med 1992;33:716–23.
- Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging
Journal of Nuclear Cardiology
Volume 15, Issue 1 , pp 73-79
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Metaiodobenzylguanidine imaging
- Industry Sectors
- Author Affiliations
- 1. Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Philadelphia, South 34th St, 19104, Philadelphia, PA
- 2. Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3. Division of Nuclear Medicine, Department of Radiology, The Children’s Hospital of Philadelphia, Philadelphia, PA